Koers DexCom, Inc. Berne S.E.
Aandelen
DC4
US2521311074
Medische apparatuur, benodigdheden & distributie
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
118,2 CHF | +7,35% | -.--% | -.--% |
Omzet 2024 * | 4,33 mld. 3,91 mld. 3,99 mld. | Omzet 2025 * | 5,15 mld. 4,65 mld. 4,75 mld. | Marktkapitalisatie | 47,23 mld. 42,6 mld. 43,55 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 732 mln. 660 mln. 675 mln. | Nettowinst (verlies) 2025 * | 910 mln. 821 mln. 839 mln. | EV/omzet 2024 * | 11,2 x |
Nettoschuld 2024 * | 1,43 mld. 1,29 mld. 1,32 mld. | Nettoschuld 2025 * | 994 mln. 897 mln. 917 mln. | EV/omzet 2025 * | 9,36 x |
K/w-verhouding 2024 * |
65,7
x | K/w-verhouding 2025 * |
53,7
x | Werknemers | 9.550 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 96,62% |
Recentste transcriptie over DexCom, Inc.
1 dag | +7,35% | ||
1 maand | +7,35% | ||
3 maanden | +5,88% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Sayer
CEO | Chief Executive Officer | 66 | 01-11-07 |
Jereme Sylvain
DFI | Director of Finance/CFO | 44 | 01-09-18 |
Chief Tech/Sci/R&D Officer | 47 | 01-10-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 65 | 20-11-09 |
Mark Foletta
BRD | Director/Board Member | 63 | 19-11-14 |
Eric Topol
BRD | Director/Board Member | 69 | 09-07-09 |
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-7,16% | 178 mld. | |
-1,23% | 107 mld. | |
-4,86% | 67,04 mld. | |
+10,32% | 44,62 mld. | |
+8,14% | 42,5 mld. | |
+15,76% | 29,99 mld. | |
+15,53% | 25,22 mld. | |
-5,88% | 24,14 mld. | |
-5,38% | 23,69 mld. |
- Beurs
- Aandelen
- Koers DXCM
- Koers DC4